GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Handok Inc (XKRX:002390) » Definitions » Total Liabilities

Handok (XKRX:002390) Total Liabilities : ₩499,495 Mil (As of Dec. 2024)


View and export this data going back to 1976. Start your Free Trial

What is Handok Total Liabilities?

Handok's Total Liabilities for the quarter that ended in Dec. 2024 was ₩499,495 Mil.

Handok's quarterly Total Liabilities increased from Jun. 2024 (₩456,317.13 Mil) to Sep. 2024 (₩490,961.71 Mil) and increased from Sep. 2024 (₩490,961.71 Mil) to Dec. 2024 (₩499,494.74 Mil).

Handok's annual Total Liabilities declined from Dec. 2022 (₩489,250.13 Mil) to Dec. 2023 (₩449,706.53 Mil) but then increased from Dec. 2023 (₩449,706.53 Mil) to Dec. 2024 (₩499,494.74 Mil).


Handok Total Liabilities Historical Data

The historical data trend for Handok's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Handok Total Liabilities Chart

Handok Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 437,077.76 457,565.42 489,250.13 449,706.53 499,494.74

Handok Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 449,706.53 475,544.61 456,317.13 490,961.71 499,494.74

Handok Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Handok's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=340995.943+(144148.008+2516.7769999999
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+5101.308+6732.7)
=499,495

Total Liabilities=Total Assets (A: Dec. 2024 )-Total Equity (A: Dec. 2024 )
=788555.007-289060.271
=499,495

Handok's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=340995.943+(144148.008+2516.7769999999
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+5101.308+6732.7)
=499,495

Total Liabilities=Total Assets (Q: Dec. 2024 )-Total Equity (Q: Dec. 2024 )
=788555.007-289060.271
=499,495

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Handok Total Liabilities Related Terms

Thank you for viewing the detailed overview of Handok's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Handok Business Description

Traded in Other Exchanges
N/A
Address
132 Teheran Street, Gangnam-gu, Seoul, KOR, 06235
Handok Inc is engaged in the healthcare sector. It is one of the leading pharmaceutical companies in Korea involved in the development of prescription drugs and OTC drugs, medical devices and in-vitro diagnostics. Its products address major diseases such as diabetes, hypertension and cardiovascular diseases.

Handok Headlines

No Headlines